UCB’s Rystiggo Becomes Second FcRn Inhibitor Treatment For gMG

Following FDA Approval

 
• By Ayisha Sharma
blue light bulb in middle of row of white light bulbs against yellow background
Rystiggo Is The First Targeted Option For Patients With MuSK • Source: Shutterstock

More from New Products

More from Scrip